USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 17, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 17, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 13, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 8, 2022 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Sep 8, 2022 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Sep 6, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 6, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 6, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 29, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 10, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 10, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 10, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 10, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 9, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 9, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 9, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 8, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; anti-cancer preparations; Pharmaceutical products for the treatment of cancer and viral and infectious diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceuticals for the treatment of cancer; Medical and scientific research in the field of cancer treatment
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PEN ROSE
Classification
International Classes
005
042